🔎 Trials Near Me

Akèy › Limfòm folikilè › Pennsylvania › Pittsburgh

Etid klinik pou Limfòm folikilè nan Pittsburgh, PA

8 etid pou Limfòm folikilè ap chèche patisipan nan sit nan ak bò kote Pittsburgh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Ap rekriteFaz 3
  • Allegheny General Hospital, Pittsburgh
  • UPMC Hillman Cancer Center, Pittsburgh
  • UPMC-Shadyside Hospital, Pittsburgh
  • ak 2 plis
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07215910

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Ap rekriteFaz 3
  • Research Site, Pittsburgh
Laj 18 a 130 · Tout sèks · Mizajou Sep 21, 2026 · NCT06549595

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Ap rekriteFaz 2
  • Research Site, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06526793

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Ap rekriteFaz 1
  • UPMC Hillman Cancer Center, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06860594

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Ap rekriteFaz 3
  • UPMC Hillman Cancer Center, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Ap rekriteFaz 1/2
  • West Penn Hospital, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma

Ap rekriteFaz 2
  • Allegheny Health Network, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Mar 23, 2026 · NCT04998669

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

Ap rekriteFaz 2
  • AHN Cancer Institute - West Penn Hospital, Pittsburgh
Laj 18 a 79 · Tout sèks · Mizajou Jan 13, 2025 · NCT05281809

Etid Limfòm folikilè nan lòt vil

Lòt etid nan Pittsburgh

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.